Adar Poonawalla
Adar Poonawalla is the CEO of Serum Institute of India, the world's largest vaccine manufacturer, known for producing critical vaccines used globally. At 44 years old, he has gained prominence not only for his leadership in the pharmaceutical industry but also for his interest in acquiring the Royal Challengers Bangalore franchise, as reported in the news. His company played a significant role in the COVID-19 vaccine development and distribution, making him a key figure in India's public health response.
Born on Jan 14, 1981 (45 years old)
Global Media Ratings
Countries Mentioned
| Country | Mentions | Sentiment | Dominance | + Persistence | x Population | = Reach | x GDP (millions) | = Power |
|---|---|---|---|---|---|---|---|---|
| Guyana | 1 | 8.00 | 0.17% | +0% | 786,552 | 1,370 | $6,000 | 10$ |
| Totals | 1 | 786,552 | 1,370 | $6,000 | 10$ |
Interactive World Map
Each country's color is based on "Mentions" from the table above.
Recent Mentions
Guyana:
Adar Poonawalla, CEO of vaccine maker Serum Institute of India, has said he will make a 'strong and competitive bid' for Royal Challengers Bengaluru.
8
India:
Adar Poonawalla plans to submit a strong and competitive bid to acquire the IPL franchise Royal Challengers Bengaluru.
8
United Kingdom:
Adar Poonawalla - India's top vaccine maker - bought a 50% stake in Karan Johar's production company for $119m.
7
Bangladesh:
Adar Poonawalla is the CEO of Serum Institute of India and the chairman of Poonawalla FinCorp.
7